BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 34988535)

  • 1. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society.
    Lenarczyk R; Zeppenfeld K; Tfelt-Hansen J; Heinzel FR; Deneke T; Ene E; Meyer C; Wilde A; Arbelo E; Jędrzejczyk-Patej E; Sabbag A; Stühlinger M; di Biase L; Vaseghi M; Ziv O; Bautista-Vargas WF; Kumar S; Namboodiri N; Henz BD; Montero-Cabezas J; Dagres N; Peichl P; Frontera A; Tzeis S; Merino JL; Soejima K; de Chillou C; Tung R; Eckardt L; Maury P; Hlivak P; Tereshchenko LG; Kojodjojo P; Atié J
    Europace; 2024 Mar; 26(4):. PubMed ID: 38584423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs.
    Larson J; Rich L; Deshmukh A; Judge EC; Liang JJ
    J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experience.
    Toniolo M; Muser D; Grilli G; Burelli M; Rebellato L; Daleffe E; Facchin D; Imazio M
    Heart Rhythm O2; 2021 Dec; 2(6Part B):840-847. PubMed ID: 34988535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks.
    Sobiech M; Lewandowski M; Zając D; Maciąg A; Syska P; Ateńska-Pawłowska J; Kowalik I; Sterliński M; Szwed H; Pytkowski M
    Kardiol Pol; 2017; 75(10):1027-1032. PubMed ID: 29057449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
    Mugnai G; Paolini C; Cavedon S; Mecenero A; Perrone C; Bilato C
    Acta Cardiol; 2022 May; 77(3):264-270. PubMed ID: 34006205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine in the Management of Recurrent Ventricular Arrhythmias: A Reappraisal.
    Li DL; Cox ZL; Richardson TD; Kanagasundram AN; Saavedra PJ; Shen ST; Montgomery JA; Murray KT; Roden DM; Stevenson WG
    JACC Clin Electrophysiol; 2021 Oct; 7(10):1254-1263. PubMed ID: 34217656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy.
    Briongos-Figuero S; Estévez A; Pérez ML; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Muñoz-Aguilera R
    ESC Heart Fail; 2020 Feb; 7(1):279-283. PubMed ID: 31823514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procainamide Versus Amiodarone for Stable Ventricular Tachycardia.
    Kelson K; deSouza I
    Acad Emerg Med; 2019 Sep; 26(9):1099-1101. PubMed ID: 31002448
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.